ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AstraZeneca Competes Viela Divestment americanpharmaceuticalreview
March 18, 2021AstraZeneca has completed the divestment of its 26.7% ownership in Viela Bio, as part of the proposed acquisition of Viela by Horizon Therapeutics. This follows the agreement to divest the shareholding on February 1, 2021. -
AstraZeneca to Divest Viela Shareholding americanpharmaceuticalreview
February 02, 2021AstraZeneca has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio, as part of the proposed acquisition of Viela by Horizon Therapeutics.
Pharma Sources Insight January 2025
